Itai Benhar

6.4k total citations
129 papers, 4.6k citations indexed

About

Itai Benhar is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Itai Benhar has authored 129 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 73 papers in Radiology, Nuclear Medicine and Imaging and 47 papers in Immunology. Recurrent topics in Itai Benhar's work include Monoclonal and Polyclonal Antibodies Research (71 papers), Glycosylation and Glycoproteins Research (33 papers) and Toxin Mechanisms and Immunotoxins (28 papers). Itai Benhar is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (71 papers), Glycosylation and Glycoproteins Research (33 papers) and Toxin Mechanisms and Immunotoxins (28 papers). Itai Benhar collaborates with scholars based in Israel, United States and Germany. Itai Benhar's co-authors include Iftach Yacoby, Yariv Mazor, Assaf Shapira, Ira Pastan, Yevgeny Berdichevsky, Yael Diesendruck, Edo Kon, Lilach Vaks, Sharon Gilead and Ehud Gazit and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Itai Benhar

125 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Itai Benhar Israel 40 2.4k 1.5k 1.1k 716 659 129 4.6k
Han‐Chung Wu Taiwan 42 3.7k 1.6× 1.3k 0.9× 790 0.7× 243 0.3× 1.3k 2.0× 169 7.1k
Tatsuya Sawasaki Japan 43 4.1k 1.7× 737 0.5× 909 0.8× 317 0.4× 439 0.7× 209 6.2k
Nico Callewaert Belgium 47 5.7k 2.4× 1.2k 0.8× 1.4k 1.2× 403 0.6× 393 0.6× 161 8.3k
Jasna Peter‐Katalinić Germany 50 5.7k 2.4× 676 0.5× 1.3k 1.2× 253 0.4× 361 0.5× 226 7.8k
Rudolf Volkmer Germany 47 6.1k 2.6× 770 0.5× 984 0.9× 324 0.5× 753 1.1× 155 8.1k
Renato Longhi Italy 52 3.9k 1.7× 623 0.4× 1.5k 1.4× 144 0.2× 890 1.4× 210 8.2k
Ruth Arnon Israel 59 3.6k 1.5× 2.0k 1.4× 3.7k 3.3× 450 0.6× 1.2k 1.8× 283 10.9k
Michel Goldberg France 37 3.8k 1.6× 1.2k 0.9× 477 0.4× 182 0.3× 229 0.3× 130 6.0k
Sophia Hober Sweden 36 3.3k 1.4× 1.9k 1.3× 350 0.3× 166 0.2× 685 1.0× 151 5.0k
Lara K. Mahal United States 40 4.7k 2.0× 1.0k 0.7× 1.3k 1.1× 138 0.2× 339 0.5× 108 5.9k

Countries citing papers authored by Itai Benhar

Since Specialization
Citations

This map shows the geographic impact of Itai Benhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itai Benhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itai Benhar more than expected).

Fields of papers citing papers by Itai Benhar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itai Benhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itai Benhar. The network helps show where Itai Benhar may publish in the future.

Co-authorship network of co-authors of Itai Benhar

This figure shows the co-authorship network connecting the top 25 collaborators of Itai Benhar. A scholar is included among the top collaborators of Itai Benhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itai Benhar. Itai Benhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Benhar, Itai, et al.. (2024). Using Combination therapy to overcome diverse challenges of Immune Checkpoint Inhibitors treatment. International Journal of Biological Sciences. 20(10). 3911–3922. 29 indexed citations
3.
Taussig, David, et al.. (2023). Antibody Isolation from Human Synthetic Libraries of Single-Chain Antibodies and Analysis Using NGS. Methods in molecular biology. 2702. 347–372.
4.
Nahmad, Alessio D., Yuval Raviv, Miriam Horovitz‐Fried, et al.. (2020). Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion. Nature Communications. 11(1). 5851–5851. 52 indexed citations
5.
Reichman, Hadar, Michal Itan, Danielle Karo‐Atar, et al.. (2020). A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis. Science Immunology. 5(44). 46 indexed citations
6.
Benhar, Itai, Yossi Manor, Thomas Wilton, et al.. (2018). A novel magnetic beads-based method for polioviral concentration from environmental samples. Journal of Virological Methods. 260. 62–69. 2 indexed citations
7.
Krinsky, Nitzan, Maya Kaduri, Janna Shainsky‐Roitman, et al.. (2016). A Simple and Rapid Method for Preparing a Cell-Free Bacterial Lysate for Protein Synthesis. PLoS ONE. 11(10). e0165137–e0165137. 39 indexed citations
8.
Herschhorn, Alon, et al.. (2013). The Isolation of Novel Phage Display-Derived Human Recombinant Antibodies Against CCR5, the Major Co-Receptor of HIV. Viral Immunology. 26(4). 277–290. 6 indexed citations
9.
Kav, Aya Brown, Itai Benhar, & Itzhak Mizrahi. (2013). A method for purifying high quality and high yield plasmid DNA for metagenomic and deep sequencing approaches. Journal of Microbiological Methods. 95(2). 272–279. 33 indexed citations
10.
11.
Gal-Tanamy, Meital, Romy Zemel, Rohit K. Jangra, et al.. (2010). Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies. Antiviral Research. 88(1). 95–106. 14 indexed citations
12.
Mazor, Yariv, Roy Noy, Winfried S. Wels, & Itai Benhar. (2007). chFRP5-ZZ-PE38, a large IgG-toxin immunoconjugate outperforms the corresponding smaller FRP5(Fv)-ETA immunotoxin in eradicating ErbB2-expressing tumor xenografts. Cancer Letters. 257(1). 124–135. 19 indexed citations
13.
Yacoby, Iftach, et al.. (2007). Targeted Drug-Carrying Bacteriophages as Antibacterial Nanomedicines. Antimicrobial Agents and Chemotherapy. 51(6). 2156–2163. 125 indexed citations
14.
Gal-Tanamy, Meital, et al.. (2005). HCV NS3 Serine Protease-neutralizing Single-chain Antibodies Isolated by a Novel Genetic Screen. Journal of Molecular Biology. 347(5). 991–1003. 19 indexed citations
15.
Denkberg, Galit, Avital Lev, Lea Eisenbach, Itai Benhar, & Yoram Reiter. (2003). Selective Targeting of Melanoma and APCs Using a Recombinant Antibody with TCR-Like Specificity Directed Toward a Melanoma Differentiation Antigen. The Journal of Immunology. 171(5). 2197–2207. 49 indexed citations
16.
Rosenfeld, Ronit, et al.. (2003). A Human Synthetic Combinatorial Library of Arrayable Single-chain Antibodies based on Shuffling in Vivo Formed CDRs into General Framework Regions. Journal of Molecular Biology. 335(1). 177–192. 43 indexed citations
17.
Benhar, Itai, et al.. (2000). Highly efficient selection of phage antibodies mediated by display of antigen as Lpp-OmpA′ fusions on live bacteria 1 1Edited by J. Wells. Journal of Molecular Biology. 301(4). 893–904. 35 indexed citations
18.
Berdichevsky, Yevgeny, Efrat Ben‐Zeev, Raphael Lamed, & Itai Benhar. (1999). Phage display of a cellulose binding domain from Clostridium thermocellum and its application as a tool for antibody engineering. Journal of Immunological Methods. 228(1-2). 151–162. 33 indexed citations
19.
Berdichevsky, Yevgeny, Raphael Lamed, Dan Frenkel, et al.. (1999). Matrix-Assisted Refolding of Single-Chain Fv– Cellulose Binding Domain Fusion Proteins. Protein Expression and Purification. 17(2). 249–259. 51 indexed citations
20.
Benhar, Itai & Ira Pastan. (1995). Identification of Residues That Stabilize the Single-chain Fv of Monoclonal Antibodies B3. Journal of Biological Chemistry. 270(40). 23373–23380. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Han‐Chung Wu Breakdown of academic impact, for papers by Tatsuya Sawasaki Breakdown of academic impact, for papers by Nico Callewaert Breakdown of academic impact, for papers by Jasna Peter‐Katalinić Breakdown of academic impact, for papers by Rudolf Volkmer Breakdown of academic impact, for papers by Renato Longhi Breakdown of academic impact, for papers by Ruth Arnon Breakdown of academic impact, for papers by Michel Goldberg Breakdown of academic impact, for papers by Sophia Hober Breakdown of academic impact, for papers by Lara K. Mahal
Rankless by CCL
2026